CAT No: CP25448
CAS No: 169555-95-7
Synonyms/Alias: 169555-95-7;Fmoc-L-4-Pyridylalanine;FMOC-4-PAL-OH;Fmoc-3-(4-pyridyl)-L-alanine;Fmoc-Ala(4-pyridyl)-OH;Fmoc-L-(4-pyridyl)alanine;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-pyridin-4-ylpropanoic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-4-yl)propanoic acid;MFCD00672566;N-FMOC-3-(4-PYRIDYL)-L-ALANINE;Fmoc-D-3-(4-pyridyl)-alanine;(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(pyridin-4-yl)propanoic acid;(2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-4-yl)propanoic acid;FMOC-3-(4'-PYRIDYL)-L-ALANINE;SCHEMBL119545;FMOC-ALA(4-PYRI)-OH;Fmoc-3-(4-pyridyl)-Ala-OH;FMOC-4'-PYRIDYL-L-ALA;Fmoc-beta-(4-pyridyl)-Ala-OH;DTXSID10359652;(S)-2-(((9H-FLUOREN-9-YL)METHOXY)CARBONYLAMINO)-3-(PYRIDIN-4-YL)PROPANOIC ACID;Fmoc- beta -(4-pyridyl)-Ala-OH;AKOS016843579;AC-9966;CS-W013878;FF48299;HY-W013162;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-(pyridin-4-yl)propanoic acid;AS-14758;AS-85928;F0927;EN300-77291;F11943;Fmoc-beta-(4-pyridyl)-Ala-OH, >=97.0% (HPLC);S-169555-95-7;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-(4-pyridyl)-L-alanine;Fmoc-L-Ala(4'-pyridyl)-OH;Fmoc-(S)-2-amino-3-(4'-pyridyl)propanoic acid;824-668-5;
Chemical Name: N-alpha-(9-Fluorenylmethyloxycarbonyl)-3-(4-pyridyl)-L-alanine
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C23H20N2O4 |
M.W/Mr. | 388.4 |
Sequence | Three Letter Code:Fmoc-4Pal-OH |
Application | Peptide synthesis; Drug screening |
Size | 1 g;5 g;25 g; |
InChI | InChI=1S/C23H20N2O4/c26-22(27)21(13-15-9-11-24-12-10-15)25-23(28)29-14-20-18-7-3-1-5-16(18)17-6-2-4-8-19(17)20/h1-12,20-21H,13-14H2,(H,25,28)(H,26,27)/t21-/m0/s1 |
InChI Key | SCSSXJVRZMQUKA-NRFANRHFSA-N |
Canonical SMILES | C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NC(CC4=CC=NC=C4)C(=O)O |
3. Cationic cell-penetrating peptides are potent furin inhibitors
4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.